---
title: "Viatris Inc. (VTRS.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/VTRS.US.md"
symbol: "VTRS.US"
name: "Viatris Inc."
industry: "Pharmaceuticals"
---

# Viatris Inc. (VTRS.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [www.viatris.com](https://www.viatris.com) |

## Company Profile

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emergi...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:13.000Z

**Overall: D (0.71)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 126 / 190 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -6.14% |  |
| Net Profit YoY | -317.90% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 1.21 |  |
| Dividend Ratio | 3.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 18.41B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 14.12B |  |


**Multi Score**: D

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -21.09% | E |
| Profit Margin | -26.13% | E |
| Gross Margin | 39.84% | B |

#### Growth Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -6.14% | D |
| Net Profit YoY | -317.90% | E |
| Total Assets YoY | -15.27% | E |
| Net Assets YoY | -23.11% | E |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -382.64% | D |
| OCF YoY | -6.14% | D |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.34 | D |

#### Debt Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 59.87% | D |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Viatris Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-21.09%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-26.13%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "39.84%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "E",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-6.14%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-317.90%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-15.27%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-23.11%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-382.64%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-6.14%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.34",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "D",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "59.87%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Eli Lilly (US.LLY) | A | A | B | E | B | B |
| 02 | ROCHE HOLDINGS AG (US.RHHVF) | A | B | B | D | C | B |
| 03 | Roche (US.RHHBY) | A | B | B | D | C | B |
| 04 | AstraZeneca (US.AZN) | A | B | C | D | C | B |
| 05 | NOVARTIS AG (US.NVS) | A | B | C | D | C | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -4.99 | 157/257 | - | - | - |
| PB | 1.21 | 57/257 | 0.85 | 0.73 | 0.63 |
| PS (TTM) | 1.30 | 37/257 | 0.91 | 0.82 | 0.72 |
| Dividend Yield | 3.00% | 11/257 | 5.45% | 4.85% | 4.19% |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-11T05:00:00.000Z

Total Analysts: **11**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 5 | 45% |
| Overweight | 1 | 9% |
| Hold | 4 | 36% |
| Underweight | 1 | 9% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 15.92 |
| Highest Target | 16.00 |
| Lowest Target | 10.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/VTRS.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/VTRS.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/VTRS.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
